Glecaprevir and Pibrentasvir generic Glecaprevir (a HCV NS3/4A protease inhibitor) and pibrentasvir (HCV NS5A phosphoprotein inhibitor) combination is used for the treatment of all genotypes (1-6) of chronic hepatitis C virus infection either without cirrhosis or with compensated early stage cirrhosis in adults. Hepatitis C is a viral disease that causes swelling of the liver which leads to reduced liver function, cirrhosis, liver failure or in some cases death. This fixed-dose combination is also used to treat adult patients suffering from HCV genotype infection 1 who have been already treated with either HCV NS3/4A protease inhibitors or HCV NS5A inhibitors but not in combination. .
More Info about Glecaprevir and Pibrentasvir